Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 10,650 shares at $1.49 ($16K) on 2021-12-21, disclosed to the SEC on 2021-12-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.49 | 2,750 | $4K | 25.7% |
| 2 | $1.51 | 3,000 | $5K | 28.4% |
| 3 | $1.49 | 4,900 | $7K | 45.8% |
| Total | $1.50 avg | 10,650 | $16K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |